Maladaptive Anger Treatment
Launched by THE UNIVERSITY OF TEXAS AT SAN ANTONIO · Feb 21, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called Cognitive Behavioral Affective Therapy (CBAT) to help people who struggle with unhealthy anger. While anger is a natural emotion, some people experience it in ways that can lead to problems in their lives, such as emotional distress or even physical health issues like high blood pressure. The goal of this trial is to see if CBAT can effectively reduce these anger issues in individuals from the community.
To participate in the trial, you need to be between the ages of 65 and 74, live in the United States, and have difficulties with anger that are not currently being treated. It’s important that you do not have serious psychiatric conditions like schizophrenia or are not receiving any other psychological help. If you join the study, you can expect to receive the CBAT treatment and take part in assessments to track your progress with anger management. This trial is currently recruiting participants, and everyone is welcome, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Live in the United States
- • Have maladaptive anger (as assessed by the STAXI-2)
- • Do not currently have any serious psychiatric illnesses (e.g., schizophrenia, autism, dementia, suicidal ideation)
- • Are not currently undergoing psychological or psychiatric treatment
- • Are not currently undergoing an anger treatment program
- • Speak English
- Exclusion Criteria:
- • Does not live in the United States
- • Does not have maladaptive anger, as assessed by the STAXI-2
- • Has a current serious psychiatric illness (e.g., schizophrenia, autism, dementia, suicidal ideation)
- • Is currently undergoing psychological or psychiatric treatment
- • Is currently undergoing an anger treatment program
- • Does not speak English
About The University Of Texas At San Antonio
The University of Texas at San Antonio (UTSA) is a prominent academic institution dedicated to advancing research and innovation in various fields, including health sciences. As a clinical trial sponsor, UTSA leverages its extensive resources and expertise to facilitate cutting-edge research aimed at improving patient outcomes and addressing critical health challenges. With a commitment to ethical practices and rigorous scientific methodology, UTSA collaborates with multidisciplinary teams to conduct clinical trials that contribute to the advancement of medical knowledge and the development of new therapies. Through its robust research programs, UTSA aims to enhance the health and well-being of diverse communities while fostering a culture of excellence in education and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported